North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Disease Indication
  • 1.2.2. End Use
  • 1.2.3. Country scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Disease indication outlook
  • 2.2.2. End use outlook
  • 2.2.3. Country outlook
• 2.3. Competitive Insights

Chapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. North America Syringe Infusion Pumps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

• 4.1. Disease Indication Segment Dashboard
• 4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
• 4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
• 4.4. Chemotherapy
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Diabetes
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Gastroenterology
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Analgesia/Pain Management
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Pediatrics/Neonatology
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Hematology
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Others
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis

• 5.1. End Use Segment Dashboard
• 5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
• 5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Homecare
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis

• 6.1. Country Market Dashboard
• 6.2. Country Market Share Analysis, 2024 & 2030
• 6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
• 6.4. U.S.
  • 6.4.1. Key country dynamics
  • 6.4.2. Regulatory framework/ reimbursement structure
  • 6.4.3. Competitive scenario
  • 6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Canada
  • 6.5.1. Key country dynamics
  • 6.5.2. Regulatory framework/ reimbursement structure
  • 6.5.3. Competitive scenario
  • 6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Mexico
  • 6.6.1. Key country dynamics
  • 6.6.2. Regulatory framework/ reimbursement structure
  • 6.6.3. Competitive scenario
  • 6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company heat map analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Baxter
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. B. Braun Medical Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Fresenius Kabi AG
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. ICU Medical, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Micrel Medical Devices SA
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Boston Scientific Corporation
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. BD
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Terumo Corporation
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Moog Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. IRadimed Corporation
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. CODAN Companies
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. ACROMED
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 North America syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 3 North America syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 4 North America syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 5 U.S. syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 6 U.S. syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 7 Canada syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 8 Canada syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
• Table 9 Mexico syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 10 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 North America syringe infusion pumps market: market outlook
• Fig. 10 North America syringe infusion pumps competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 North America syringe infusion pumps market driver impact
• Fig. 16 North America syringe infusion pumps market restraint impact
• Fig. 17 North America syringe infusion pumps market strategic initiatives analysis
• Fig. 18 North America syringe infusion pumps market: Disease indication movement analysis
• Fig. 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
• Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
• Fig. 21 Diabetes estimates and forecast, 2018 - 2030
• Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
• Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
• Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
• Fig. 25 Hematology estimates and forecast, 2018 - 2030
• Fig. 26 Others estimates and forecast, 2018 - 2030
• Fig. 27 North America syringe infusion pumps market: End use movement analysis
• Fig. 28 North America syringe infusion pumps market: End use outlook and key takeaways
• Fig. 29 Hospitals estimates and forecast, 2018 - 2030
• Fig. 30 Homecare estimates and forecast, 2018 - 2030
• Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
• Fig. 32 North America syringe infusion pumps market: Country movement analysis
• Fig. 33 North America syringe infusion pumps market: Country outlook and key takeaways
• Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 35 Canada market estimates and forecasts, 2018 - 2030
• Fig. 36 Mexico market estimates and forecasts, 2018 - 2030